Inventiva (IVA) shares were up more than 65% pre-bell Monday after the company said it secured up to 348 million euros ($379.9 million) in equity financing to advance its phase 3 trial of a treatment candidate for metabolic dysfunction-associated steatohepatitis.
Expion360 (XPON) stock was 57% higher following a 3.9% gain in the previous session.
Longboard Pharmaceuticals (LBPH) shares were up 51% after the company said it agreed to be acquired by Lundbeck in a deal valued at $2.60 billion.
Jasper Therapeutics (JSPR) stock was 26% higher after the company reported that 14 of 15 patients enrolled in both dose cohorts of its phase 1b/2a trial of a treatment candidate for chronic inducible urticaria achieved a clinical response.
B. Riley Financial (RILY) shares were up nearly 23% after the company said it has agreed to sell its Great American Group unit to Oaktree in a deal valued at $386 million.
Price: 3.1300, Change: +1.24, Percent Change: +65.61
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。